1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Coronary Artery Bypass Graft: new trials by email Literature Review of Coronary Artery Bypass Graft trials Research Report on Coronary Artery Bypass Graft
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass pexelizumab - Cardio-pulmonary Bypass, Coronary Artery Bypass Graft | Phase 3 | Completed | Alexion Pharmaceuticals, Inc. | 3000 | 2002-01-01 | 2017-02-23 |
pexelizumab (1)
Alexion Pharmaceuticals, Inc. (1)
Canada (1) · United States (1)